Literature DB >> 7891274

Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol.

J J Wheeler1, K F Wong, S M Ansell, D Masin, M B Bally.   

Abstract

A stable lipid-based carrier system containing a triacylglycerol core has been developed. This has been achieved by homogenization of corn oil (primarily triacylglycerol) in the presence of phosphatidylcholine (PC), preformed 100 nm liposomes prepared from PC/cholesterol (55: 45; mol:mol) and polyethylene glycol modified phosphatidylethanolamine (PEG2000-PE). The lipid/liposome mixtures were emulsified using a microfluidizer, and the resulting particles could, depending on the phospholipids used and the addition of cholesterol, be designed to exhibit a uniform mean particle size of less than 100 nm (as measured by quasielastic light scattering). The presence of an oil core within the emulsified lipid preparation was confirmed by freeze-fracture and cryoelectron microscopy. Stability of the resulting PEG2000-PE-coated triacylglycerol emulsion was determined by several techniques including (1) time dependent changes in light scatter determined by measuring changes in absorbance at 600 nm (decreases in absorbance are indicative of unstable oil emulsions), (2) column chromatography procedures evaluating the migration of incorporated lipids, specifically PEG2000-PE and triolein, after emulsions were incubated at 37 degrees C in the presence and absence of serum, and (3) in vivo plasma clearance data demonstrating that the lipid mixtures were maintained at ratios specified prior to i.v. administration. This emulsion technology has been used to prepare formulations of several water insoluble compounds, such as the drugs taxol and dibucaine and the lipophilic dye sudan IV.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7891274     DOI: 10.1002/jps.2600831108

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  8 in total

1.  Improved DNA/emulsion complex stabilized by poly(ethylene glycol) conjugated phospholipid.

Authors:  S Chesnoy; D Durand; J Doucet; D B Stolz; L Huang
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 2.  Injectable lipid emulsions-advancements, opportunities and challenges.

Authors:  Ketan Hippalgaonkar; Soumyajit Majumdar; Viral Kansara
Journal:  AAPS PharmSciTech       Date:  2010-10-26       Impact factor: 3.246

3.  A cationic lipid emulsion/DNA complex as a physically stable and serum-resistant gene delivery system.

Authors:  S W Yi; T Y Yune; T W Kim; H Chung; Y W Choi; I C Kwon; E B Lee; S Y Jeong
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

4.  Optimization of lipid composition in cationic emulsion as in vitro and in vivo transfection agents.

Authors:  T W Kim; H Chung; I C Kwon; H C Sung; S Y Jeong
Journal:  Pharm Res       Date:  2001-01       Impact factor: 4.200

5.  Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network.

Authors:  Tianyuan Fan; Kozo Takayama; Yoshiyuki Hattori; Yoshie Maitani
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

6.  Protein Crowding Is a Determinant of Lipid Droplet Protein Composition.

Authors:  Nora Kory; Abdou-Rachid Thiam; Robert V Farese; Tobias C Walther
Journal:  Dev Cell       Date:  2015-07-23       Impact factor: 12.270

7.  Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.

Authors:  Emi Ishida; Chittima Managit; Shigeru Kawakami; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2004-06       Impact factor: 4.200

8.  Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs.

Authors:  F Liu; D Liu
Journal:  Pharm Res       Date:  1995-07       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.